Fitting mSMART Into the Current Clinical Management of Waldenström Macroglobulinemia.
Sign Up to like & getrecommendations! Published in 2018 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2017.0734
Abstract: Fitting mSMART Into the Current Clinical Management of Waldenström Macroglobulinemia To the Editor We read with interest the article outlining the 2016 mSMART guidelines for the diagnosis and management of Waldenström macroglobulinemia (WM).1 We believe… read more here.
Keywords: rituximab; management waldenstr; waldenstr macroglobulinemia;
A British view on the management of Waldenström macroglobulinemia
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18070
Abstract: In this issue of the Journal, the British Society of Haematology (BSH) publishes guidelines for the diagnosis and management of patients with Waldenström macroglobulinemia (WM),1 a rare Bcell lymphoma with plasmacytic differentiation (lymphoplasmacytic lymphoma, per… read more here.
Keywords: british view; journal; waldenstr macroglobulinemia; view management ... See more keywords
New developments in the management of Waldenström macroglobulinemia
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Management and Research"
DOI: 10.2147/cmar.s94059
Abstract: Waldenström macroglobulinemia (WM) is a rare, immunoglobulin M -associated lymphoplasmacytic lymphoma. With the recent discoveries of CXCR warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) and MYD88 mutations, our understanding of the biology of WM has expanded… read more here.
Keywords: waldenstr macroglobulinemia; new developments; developments management; management waldenstr ... See more keywords